Approval · Notice of Compliance 30315 · 2023
CLOLAR: Notice of Compliance 30315
Issued March 13, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30315
- Date
- March 13, 2023
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update the inner and outer labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CLOLAR | Not yet assigned | — |
Medicinal ingredients
- CLOFARABINE 1 MG per ML